GGrantIndex
Sort

48,018 grants matching immunotherapy

Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders

$3,423,644
Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL

CD5-deleted chimeric antigen receptor cells (Senza5 CART5) to enhance immunotherapy against T cell non-Hodgkin lymphoma (NHL): a first-in-human phase I clinical trial

$3,421,591
Stefan Klaus Barta · University Of Pennsylvania · R01 · FY2025 · FD

DEVELOPING THE FRAMEWORK FOR FIRST-IN-CLASS IMMUNOTHERAPIES THAT TARGET DISSEMINATED TUMOR CELLS AND PREVENT BREAST CANCER METASTASIS

$3,421,440
Fred Hutchinson Cancer Center · · FY2020 · Defense Health Agency

TCR Gene Modified T Cells for Adoptive Immunotherapy

$3,406,082
Michael I Nishimura · Loyola University Chicago · P01 · FY2015 · CA

Development of an Integrated Canine Data Commons (ICDC)

$3,403,168
John Otridge · Leidos Biomedical Research, Inc. · N01 · FY2019 · CA

DCTD Division of Cancer Tratment and DIagnosis

$3,400,000
Ethan Dmitrovsky · Leidos Biomedical Research, Inc. · N01 · FY2020 · CA

Integrated Approach to Host-Pathogen Interactions

$3,389,290
Mary R Galinski · Emory University · N01 · FY2012 · AI

Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS

$3,386,683
Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2016 · CA

The Therapy of CML

$3,383,296
Richard E. Champlin · University Of Tx Md Anderson Can Ctr · P01 · FY2013 · CA

VACCINE INDUCED IMMUNITY IN THE YOUNG AND AGED

$3,378,054
Rafi Ahmed · Emory University · U19 · FY2007 · AI

Metabolic reprogramming of tumor microenvironment to maximize immunotherapy for pediatric cancers

$3,370,657
Ruoning Wang · Research Inst Nationwide Children'S Hosp · U01 · FY2018 · CA

Cancer Immunotherapy Trials Network Central Operations and Statistical Center

$3,368,475
Martin Cheever · Fred Hutchinson Cancer Research Center · U01 · FY2012 · CA

Pediatric Brain Tumor ConsortiumA multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors.

$3,361,716
Arzu Onar-Thomas · St. Jude Children'S Research Hospital · UM1 · FY2023 · CA

CANCER CENTER SUPPORT GRANT

$3,352,603
University Of Colorado Denver · P30 · FY2002 · CA

RADIOIMMUNOTHERAPY OF CANCER

$3,346,153
Ctr For Molecular Medicine/Immunology · P01 · FY2000 · CA

Multiple Approaches to Abeta Vaccination in Animal Models

$3,340,325
Michael G Agadjanyan · Institute For Molecular Medicine · RF1 · FY2018 · AG

ARIA Pathophysiology Characterized by in vivo Neuroimaging, Plasma Biomarkers and Post-Mortem Proteomics

$3,310,951
Thomas M Wisniewski · New York University School Of Medicine · U24 · FY2025 · NS

THERAPEUTIC INDEX OF ACUTE LYMPHOBLASTIC LEUKEMIA

$3,307,331
Dana-Farber Cancer Institute · P01 · FY2004 · CA

Clinical Islet Transplantation: Data Coordinating Center

$3,307,134
William R Clarke · University Of Iowa · U01 · FY2008 · DK

Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS

$3,304,387
Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2015 · CA

Single-cell DNA methylation analysis of human cancer

$3,296,269
Kenneth Aldape · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

TCR Gene Modified T Cells for Adoptive Immunotherapy

$3,295,681
Michael I Nishimura · Loyola University Chicago · P01 · FY2014 · CA

Cancer Center Support Grant

$3,290,263
Mark A Israel · Dartmouth College · P30 · FY2009 · CA

Cancer Center Support Grant

$3,290,263
Mark A Israel · Dartmouth College · P30 · FY2010 · CA

Simian Vaccine Evaluation Unit (SVEU)

$3,283,375
Michael Agy · University Of Washington · N01 · FY2012 · AI